Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Mar 6, 2017, after the close
10-K filed Mar 6, 2017, 65 days after period end · 0001299130-17-000016
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Revenue | $25.72M | $36.28M | $16.90M | $9.13M |
| Net Income | -$19.03M | -$1.41M | -$18.98M | -$17.23M |
| EPS Diluted | — |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.02 |
| — |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
